Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
| Medication | Monthly Cost (2026) | Mechanism | Avg Weight Loss | |-----------|-------------------|-----------|-----------------| | Retatrutide (compounded) | $200650 | Triple agonist (GLP-1/GIP/glucagon) | 24% | | Wegovy (semaglutide) | $1,300+ | GLP-1 only | 15% | | Zepbound (tirzepatide) | $1,059+ | Dual agonist (GLP-1/GIP) | 21% | | Mounjaro (tirzepatide) | $1,023+ | Dual agonist (GLP-1/GIP) | 21% | | Ozempic (semaglutide) | $935+ | GLP-1 only | 12-14% | *Note: Compounded retatrutide prices reflect direct pharmacy costs with valid prescription
Trends Microbiol
Cho CE, Caudill MA
Emerging compounds and their hair loss profiles Newer medications in the GLP-1 family and related classes are entering the market
MHRA-approved and NICE-recommended alternatives include semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), available via NHS specialist services or regulated private clinics
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
